Literature DB >> 33144189

Assembly strategy of liposome and polymer systems for siRNA delivery.

Huiling Song1, Stephen L Hart2, Zixiu Du3.   

Abstract

In recent years, gene therapy has made tremendous progress in the development of disease treatment. Among them, siRNA offers specificity of gene silencing, ease of synthesis, and short development period, and has been intensively studied worldwide. However, siRNA as the hydrophilic polyanion is easily degraded in vivo and poorly taken up into cells and so, the benefits of its powerful gene silencing ability will not be realized until better carriers are developed that are capable of protecting siRNA and delivering it intact to the cytoplasm of the target cells. Cationic liposomes (CL) and cationic polymers (CP) are the main non-viral siRNA vectors, there have been a lot of reports on the use of these two carriers to deliver siRNA. Whereas, as far as we know, there have been few review articles that provide an in-depth summary of the siRNA loading principle and internal structures of the siRNA delivery system. We summarize the formation principle and assembly structure of the cationic liposome-siRNA and polymer-siRNA complexes, and point out their advantages and characteristics and also show how to perfect their assembly and improve their clinical application in the future. It supports some useful suggestions for siRNA therapy, specifically, safe and efficient delivery.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Assembly structure; Cationic liposome; Cationic polymer; HA modified RTN; Liposome-polycation-siRNA (LPR); Receptor-targeted-nanocomplexes (RTN); siRNA delivery system

Year:  2020        PMID: 33144189     DOI: 10.1016/j.ijpharm.2020.120033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.

Authors:  Tinnabhop Santadkha; Wanwisa Skolpap; Remant K C; Aysha Ansari; Cezary Kucharski; Teo Atz Dick; Hasan Uludağ
Journal:  Invest New Drugs       Date:  2022-07-14       Impact factor: 3.651

2.  Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes.

Authors:  Yoshiyuki Hattori; Min Tang; Satomi Torii; Kana Tomita; Ayane Sagawa; Nodoka Inoue; Reo Yamagishi; Kei-Ichi Ozaki
Journal:  Mol Med Rep       Date:  2022-06-10       Impact factor: 3.423

3.  Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor.

Authors:  Lara Diego-González; Andrea Fernández-Carrera; Ana Igea; Amparo Martínez-Pérez; M Elisabete C D Real Oliveira; Andreia C Gomes; Carmen Guerra; Mariano Barbacid; África González-Fernández; Rosana Simón-Vázquez
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

4.  A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1).

Authors:  Zhanxia Zhang; Junqian Zhang; Jianhui Tian; Hegen Li
Journal:  J Nanobiotechnology       Date:  2021-10-15       Impact factor: 10.435

5.  Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma.

Authors:  Monica Argenziano; Federica Bessone; Chiara Dianzani; Marie Angèle Cucci; Margherita Grattarola; Stefania Pizzimenti; Roberta Cavalli
Journal:  Pharmaceutics       Date:  2022-01-31       Impact factor: 6.321

6.  Efficient Treatment of Rheumatoid Arthritis by Degradable LPCE Nano-Conjugate-Delivered p65 siRNA.

Authors:  Xiaohua Chen; Bailing Zhou; Yan Gao; Kaiyu Wang; Jieping Wu; Ming Shuai; Ke Men; Xingmei Duan
Journal:  Pharmaceutics       Date:  2022-01-11       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.